Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: SWOG Cancer Research Network
Condition: Breast Cancer
NCT00856492
S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.